Pathologic Staging Results in Substantially Higher Risk-stratification Compared with that Predicted by Clinical Risk-stratification in Men with Adenocarcinoma of the Prostate

被引：0
|
作者：
Cooke, E. W. [1 ]
Shrieve, D. C. [1 ]
Tward, J. D. [1 ]
机构：
[1] Univ Utah, Huntsman Canc Hosp, Salt Lake City, UT USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2009年 / 75卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2009.07.685
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S297 / S298
页数：2
相关论文
共 50 条
  • [41] Linking cellular metabolism and metabolomics to risk-stratification of prostate cancer clinical aggressiveness and potential therapeutic pathways
    Eidelman, Eric
    Tripathi, Hemantkumar
    Fu, De-Xue
    Siddiqui, M. Minhaj
    [J]. TRANSLATIONAL ANDROLOGY AND UROLOGY, 2018, 7 : S490 - S497
  • [42] Predicting inpatient delirium: The AWOL delirium risk-stratification score in clinical practice
    Brown, Ethan G.
    Josephson, S. Andrew
    Anderson, Noriko
    Reid, Mary
    Lee, Melissa
    Douglas, Vanja C.
    [J]. GERIATRIC NURSING, 2017, 38 (06) : 567 - 572
  • [43] Mantle cell lymphoma: 2017 update on diagnosis, risk-stratification, and clinical management
    Vose, Julie M.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (08) : 806 - 813
  • [44] Mantle cell lymphoma: 2015 update on diagnosis, risk-stratification, and clinical management
    Vose, Julie M.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (08) : 739 - 745
  • [45] CLINICAL, PATHOLOGICAL, AND MOLECULAR VARIABLES DEFINE RISK-STRATIFICATION GROUPS IN CHILDHOOD MEDULLOBLASTOMA
    Ellison, D. W.
    Megahed, H.
    Kocak, M.
    Dalton, J.
    Ryan, S. L.
    Lusher, M.
    Fraga, C.
    Zhao, W.
    Nicholson, S. L.
    Robinson, K.
    Taylor, R. E.
    Bailey, S.
    Clifford, S. C.
    [J]. NEURO-ONCOLOGY, 2010, 12 (06) : II2 - II2
  • [46] Mantle cell lymphoma: 2012 update on diagnosis, risk-stratification, and clinical management
    Vose, Julie M.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (06) : 605 - 609
  • [47] Machine learning on clinical data for mortality risk-stratification after radiotherapy for NSCLC
    Hindocha, S.
    Charlton, T.
    Linton-Reid, K.
    Hunter, B.
    Chan, C.
    Ahmed, M.
    Robinson, E.
    Orton, M.
    Ahmad, S.
    McDonald, F.
    Locke, I.
    Power, D.
    Blackledge, M.
    Lee, R.
    Aboagye, E.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S773 - S774
  • [48] Clinical, Pathological, and Molecular Variables Define Risk-Stratification Groups in Childhood Medulloblastoma
    Ellison, David
    Kocak, Mehmet
    Dalton, James
    Megahed, Hisham
    Ryan, Sarra
    Lusher, Meryl
    Nicholson, Sarah
    Bailey, Simon
    Taylor, Roger
    Zhao, Wei
    Clifford, Steven
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2010, 69 (05): : 529 - 529
  • [49] THE VALUE OF DYNAMIC CONTRAST ENHANCEMENT FOR RISK-STRATIFICATION AND PROSTATE CANCER DETECTION ON MULTIPARAMETRIC PROSTATE MRI
    Li, Eric
    Siddiqui, Mohammad
    Aguiar, Jonathan
    Shah, Parth
    Mahenthiran, Ashorne
    Lin, Jasmine
    Soliman, Moataz
    Kumar, Sai
    Keeter, Mary Kate
    Neill, Clayton
    Mi, Xinlei
    Mai, Quan
    Schaeffer, Edward
    Ross, Ashley
    Patel, Hiten
    [J]. JOURNAL OF UROLOGY, 2023, 209 : E614 - E615
  • [50] COMBINED CLINICAL AND CYTOGENETIC PROGNOSTIC MARKERS GREATLY ENHANCES RISK-STRATIFICATION OF MEDULLOBLASTOMA
    Shih, David J. H.
    Northcott, Paul A.
    Remke, Marc
    Korshunov, Andrey
    Jones, DavidT. W.
    Kool, Marcel
    Pfister, Stefan M.
    Taylor, Michael D.
    [J]. NEURO-ONCOLOGY, 2013, 15 : 49 - 50
12345